Karen Canfell is the Director, Cancer Research Division at Cancer Council NSW, Chair of Cancer Council Australia’s Cancer Screening and Immunisation Committee, and Adjunct Professor, University of Sydney.
She leads a program of research which provides policy-makers with an evidence-base for decision making in cancer control. To date, a focus has been the interplay between HPV vaccination and cervical screening in both high and low resource countries. Her group regularly performs economic evaluations of new screening technologies for government agencies in Australia, New Zealand and England and she is a co-PI of an US NCI collaborative research grant, CISNET-Cervical, to evaluate new vaccination and screening options in the USA.
Karen's group's work underpins the current Renewal (review) of the National Cervical Screening Program which involves an imminent 2017 transition to HPV-based screening. Karen is also co-PI of Compass, a major Australian trial of cervical screening which is acting as a sentinel experience for the new cervical screening program.
NHMRC National Award for Research Excellence, 2015; Westpac & AFR 2015 'Woman of Influence'